Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Red Cross receives two coffins of deceased hostages...
Trump surgeon general nominee confirmation hearing postponed as...
Vance to meet with Duffy, aviation leaders as...
Once a trade war weapon, US soybeans return...
Republican senators blast FDA for expanding abortion pill...
Senate defies Trump on global tariffs as Republicans...
House Republicans divided over Obamacare as GOP eyes...
Thune, GOP reject pushing ‘rifle-shot’ government funding bills...
Trump’s fire fades on Russia as he pulls...
GOP lawmaker says backing Cuomo over ‘communist’ Mamdani...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Pro-life group urges Senate to press RFK Jr. on abortion pill safety, demand safeguards return

by admin September 4, 2025
September 4, 2025
Pro-life group urges Senate to press RFK Jr. on abortion pill safety, demand safeguards return

The Restoration of America Foundation (ROAF) is calling on the Senate Finance Committee to hold Health and Human Services Secretary Robert F. Kennedy Jr. accountable at Thursday’s 10 a.m. hearing, demanding answers about the removal of safety protocols for the abortion pill mifepristone.

In a letter provided exclusively to Fox News Digital, ROAF argues the rollback leaves women more vulnerable and shifts costs to taxpayers.

ROAF argues that the Biden-era rollback of Risk Evaluation and Mitigation Strategy (REMS) requirements, safeguards in place for more than two decades, endangers women by allowing abortion pills to be prescribed via telehealth and delivered through the mail.

‘The removal of key Risk Evaluation and Mitigation Strategy (REMS) requirements for mifepristone has eliminated essential safeguards that protected women’s health for over two decades,’ said Doug Truax, founder and CEO of the Restoration of America Foundation. ‘We urge the Senate to demand clear answers about why these safety protocols were removed and when they will be reinstated.’

The Food and Drug Administration originally required mifepristone to be dispensed in person to ensure women were screened for potential complications such as ectopic pregnancy. That changed under the Biden administration, when telehealth prescribing and mail-order delivery were permitted for the first time.

Truax warned that ‘allowing these powerful drugs to be ordered online and sent through the mail without proper medical screening puts women at serious risk.’ He added, ‘Women deserve to know about potential complications and have immediate access to emergency care if needed.’

This post appeared first on FOX NEWS

previous post
US bolsters military presence in Caribbean near Venezuela amid Trump’s efforts to halt drug trafficking
next post
Trump’s political advisors huddle with House GOP over rebranding of the big beautiful bill

You may also like

Trump picks Billy Long to head IRS, Kelly...

December 5, 2024

Kim Jong Un shows off ‘most powerful’ ballistic...

October 11, 2025

Who could lead if Zelenskyy resigned?

March 1, 2025

Shutdown averted after Schumer caves and backs Trump...

March 15, 2025

‘Most damning evidence’: Hunter Biden’s full pardon resurfaces...

December 6, 2024

Trump team holds ‘constructive’ face-to-face nuclear talks with...

April 13, 2025

Trump draws laughs from world leaders moments into...

September 23, 2025

Trump says Iran would ‘like to talk’ about...

June 17, 2025

Who is Kash Patel? Trump’s pick to lead...

December 2, 2024

Energy expert weighs in on 23 state attorneys...

January 18, 2025

Recent Posts

  • Red Cross receives two coffins of deceased hostages in Gaza Strip, IDF says
  • Trump surgeon general nominee confirmation hearing postponed as she goes into labor
  • Vance to meet with Duffy, aviation leaders as shutdown ‘gravely’ impacts crucial industry
  • Once a trade war weapon, US soybeans return to China’s shopping list
  • Republican senators blast FDA for expanding abortion pill access

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (946)
    • Investing (3,314)
    • Politics (4,055)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.